# A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions

> **NCT00870974** · PHASE1 · COMPLETED · sponsor: **Institute for Neurodegenerative Disorders** · enrollment: 48 (actual)

## Conditions studied

- Parkinson Disease
- Huntington Disease
- Autistic Spectrum Disorders
- Fragile X Syndrome
- Alzheimer Disease
- Mild Cognitive Impairment

## Interventions

- **DRUG:** [18F]FPEB

## Key facts

- **NCT ID:** NCT00870974
- **Lead sponsor:** Institute for Neurodegenerative Disorders
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2016-10
- **Final completion:** 2016-11
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2017-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00870974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00870974, "A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00870974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*